Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction. Arterial dysfunction in obesity and diabetes

Journal of Diabetes and its Complications

Volumn 21, Issue 3, 2007, Pages 149-157

  Sivitz, William I ^a,b   Wayson, Sheila M ^a,b   Bayless, Margaret L ^a,b   Sinkey, Christine A ^a,b   Haynes, William G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Acetylcholine; Arteries; Diabetes mellitus; Endothelium; Nitric oxide; Norepinephrine; Obesity

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ADRENERGIC ACTIVITY; ADULT; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOOTH MUSCLE CONTRACTION; VASOCONSTRICTION; VASODILATATION;

ADIPOSE TISSUE; BLOOD FLOW VELOCITY; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NITROPRUSSIDE; NOREPINEPHRINE; OBESITY; OMEGA-N-METHYLARGININE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 34247586046     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.12.003     Document Type: Article

References (27)

1. Al Suwaidi J., Higano S.T., Holmes Jr. D.R., Lennon R., and Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. Journal of the American College of Cardiology 37 (2001) 1523-1528
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 27 (2004) S15-S35
3. Arcaro G., Zamboni M., Rossi L., Turcato E., Covi G., Armellini F., Bosello O., and Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 23 (1999) 936-942
4. Bergholm R., Tiikkainen M., Vehkavaara S., Tamminen M., Teramo K., Rissanen A., et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care 26 (2003) 1667-1672
5. Bergman R.N., Finegood D.T., and Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews 6 (1985) 45-86
6. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., and Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. American Journal of Cardiology 88 (2001) 1264-1269
7. Coates P.A., Luzio S.D., Brunel P., and Owens D.R. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 44 (1995) 631-635
8. Di Carli M.F., Janisse J., Grunberger G., and Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. Journal of the American College of Cardiology 41 (2003) 1387-1393
9. Et-Taouil K., Safar M., and Plante G.E. Mechanisms and consequences of large artery rigidity. Canadian Journal of Physiology & Pharmacology 81 (2003) 205-211
10. Goodfellow J., Ramsey M.W., Luddington L.A., Jones C.J., Coates P.A., Dunstan F., Lewis M.J., Owens D.R., and Henderson A.H. Endothelium and inelastic arteries: An early marker of vascular dysfunction in non-insulin dependent diabetes. British Medical Journal 312 (1996) 744-745
11. Hashimoto M., Akishita M., Eto M., Kozaki K., Ako J., Sugimoto N., Yoshizumi M., Toba K., and Ouchi Y. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 22 (1998) 477-484
12. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Chayama K., and Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. American Journal of Hypertension 14 (2001) 1038-1045
13. Hogikyan R.V., Galecki A.T., Halter J.B., and Supiano M.A. Heightened norepinephrine-mediated vasoconstriction in type 2 diabetes. Metabolism: Clinical and Experimental 48 (1999) 1536-1541
14. Hogikyan R.V., Galecki A.T., Pitt B., Halter J.B., Greene D.A., and Supiano M.A. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. Journal of Clinical Endocrinology and Metabolism 83 (1998) 1946-1952
15. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., and Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100 (1999) 1161-1168
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
17. McVeigh G.E., Brennan G.M., Johnston G.D., McDermott B.J., McGrath L.T., Henry W.R., Andrews J.W., and Hayes J.R. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 (1992) 771-776
18. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., and Attali J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42 (1993) 1017-1025
19. Pitkanen O.P., Nuutila P., Raitakari O.T., Ronnemaa T., Koskinen P.J., Iida H., Lehtimaki T.J., Laine H.K., Takala T., Viikari J.S., and Knuuti J. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47 (1998) 248-254
20. Putz D.G.W.S., Bar R.S., Haynes W.G., and Sivitz W.I. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism Clinical & Experimental 53 (2004) 1454-1461
21. Sivitz W.I., Wayson S.M., Bayless M.L., Larson L.F., Sinkey C., Bar R.S., et al. Leptin and body fat in type 2 diabetes and monodrug therapy. Journal of Clinical Endocrinology Metabolism 88 (2003) 1543-1553
22. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., and Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. Journal of Clinical Investigation 97 (1996) 2601-2610
23. Steinberg H.O., Paradisi G., Cronin J., Crowde K., Hempfling A., Hook G., and Baron A.D. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 101 (2000) 2040-2046
24. Tack C.J., Ong M.K., Lutterman J.A., and Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 41 (1998) 569-576
25. Watts G.F., O'Brien S.F., Silvester W., and Millar J.A. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia. Clinical Science 91 (1996) 567-573
26. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., and Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 27 (1996) 567-574
27. Yokoyama I., Momomura S., Ohtake T., Yonekura K., Nishikawa J., Sasaki Y., et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 30 (1997) 1472-1477